Pamela Stephenson
Corporate Officer/Principal en DISC MEDICINE, INC. .
Fortuna: 972 382 $ al 30/04/2024
Cargos activos de Pamela Stephenson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 26/02/2024 | - |
Historial de carrera de Pamela Stephenson
Antiguos cargos conocidos de Pamela Stephenson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 19/02/2019 | 10/10/2023 |
| Independent Dir/Board Member | 19/02/2019 | 10/10/2023 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/07/2008 | 01/03/2019 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 25/03/2019 | - |
Formación de Pamela Stephenson.
| Brown University | Undergraduate Degree |
| Boston University School of Public Health | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| DISC MEDICINE, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Pamela Stephenson
- Experiencia